
The spin-off of the University of Barcelona, Braingaze, consolidates an investment of 1.5 million euros to introduce innovative solutions in the cognitive health market .
Specializing in digital cognitive health, Braingaze has successfully secured an investment that will accelerate both the clinical and business development of its diagnostic and therapeutic solutions for cognitive disorders and neurodegenerative diseases . These solutions include the treatment of ADHD, Alzheimer's disease, and autism spectrum disorder, among others.
The company has participated in the Industrial Doctorate Plan since 2013 with three industrial doctorate projects . Its technology combines patented biomarkers of eye micromovements, home video games and deep learning algorithms. This makes it possible to provide diagnostics with industry-leading accuracy and objectivity, as well as therapeutic solutions that improve levels of cognitive function, overcoming the limitations of conventional treatments.
Braingaze's ADHD diagnostic solutions are already used in clinical practice in the Spanish market, demonstrating their effectiveness and acceptance.
Braingaze's success in this investment round reflects the market's confidence in its innovative technology, as well as its ability to improve the quality of life of people affected by cognitive and neurodegenerative disorders .
For more information you can consult:
– The UB spin-off, Braingaze, closes an investment of 1.5 million euros to bring cognitive health solutions to the market (03-06-2024 | http://www.fbg.ub.edu)